Human genetics as a foundation for innovative drug development

Nature Biotechnology

Volumn 31, Issue 11, 2013, Pages 975-978

  Kamb, Alexander ^a   Harper, Sean ^a   Stefansson, Kari ^b  

^a AMGEN INC   (United States)

^b DECODE GENETICS   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AFAMELANOTIDE; AMBRISENTAN; CARVEDILOL; CINACALCET; DENOSUMAB; ESETIMIBE; FENOFIBRATE; FENTANYL; GABAPENTIN; HIGH DENSITY LIPOPROTEIN; HUMAN GROWTH HORMONE; HYPOCHOLESTEROLEMIC AGENT; LASOFOXIFENE; LIPROTAMASE; METFORMIN; MIPOMERSEN; PEGAPTANIB; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ROSIGLITAZONE; ROXIFIBAN; SIMVASTATIN; SITAGLIPTIN; TAGATOSE; TEDISAMIL; TORCETRAPIB; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; USTEKINUMAB; VARENICLINE;

ATHEROSCLEROSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; DWARFISM; EPILEPSY; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN GENETICS; HYPERCALCEMIA; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; NEUTROPENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OSTEOPOROSIS; PAIN; PANCREAS INSUFFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; RETINA MACULA DEGENERATION; RHEUMATOID ARTHRITIS; SKIN DISEASE; THROMBOSIS; TOBACCO DEPENDENCE;

CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; GENETICS, MEDICAL; HUMANS;

EID: 84887435979     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2732     Document Type: Note

References (40)

1. Lewis, E.B. Nature 276, 565-570 (1978).
2. Fishman, M.C. & Porter, J.A. Nature 437, 491-493 (2005).
3. Paul, S.M. et al. Nat. Rev. Drug Discov. 9, 203-214 (2010).
4. Laurie, S.A. & Goss, G.D. J. Clin. Oncol. 31, 1061-1069 (2013).
5. Wellcome Trust Case Control Consortium. Nature 447, 661-678 (2007).
6. Gudmundsson, J. et al. Sci. Transl. Med. 2, 62ra92 (2010).
7. Kannel, W.B. & Castelli, W.P. Med. Times 100, 173-175 (1972).
8. Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B. & Dawber, T.R. Am. J. Med. 62, 707-714 (1977).
9. The AIM-HIGH Investigators. N. Engl. J. Med. 365, 2255-2267 (2011).
10. Barter, P.J. et al. N. Engl. J. Med. 357, 2109-2122 (2007).
11. Schwartz, G.G. et al. N. Engl. J. Med. 367, 2089-2099 (2012).
12. Voight, B.F. et al. Lancet 380, 572-580 (2012).
13. Cohen, J. et al. Nat. Genet. 37, 161-165 (2005).
14. Zhao, Z. et al. Am. J. Hum. Genet. 79, 514-523 (2006).
15. Hooper, A.J., Marais, A.D., Tanyanyiwa, D.M. & Burnett, J.R. Atherosclerosis 193, 445-448 (2007).
16. Lambert, G., Sjouke, B., Choque, B., Kastelein, J.J. & Hovingh, G.K. J. Lipid Res. 53, 2515-2524 (2012).
17. Haddad, L. et al. J. Lipid Res. 40, 1113-1122 (1999).
18. Abifadel, M. et al. Nat. Genet. 34, 154-156 (2003).
19. Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr. & Hobbs, H.H. N. Engl. J. Med. 354, 1264-1272 (2006).
20. Benn, M., Nordestgaard, B.G., Grande, P., Schnohr, P. & Tybjaerg-Hansen, A. J. Am. Coll. Cardiol. 55, 2833-2842 (2010).
21. J. Am. Med. Assoc. 251, 351-364 (1984).
22. J. Am. Med. Assoc. 251, 365-374 (1984).
23. Stamler, J., Wentworth, D. & Neaton, J.D. J. Am. Med. Assoc. 256, 2823-2828 (1986).
24. Pekkanen, J. et al. N. Engl. J. Med. 322, 1700-1707 (1990).
25. Wong, N.D., Wilson, P.W. & Kannel, W.B. Ann. Intern. Med. 115, 687-693 (1991).
26. Rossouw, J.E., Lewis, B. & Rifkind, B.M. N. Engl. J. Med. 323, 1112-1119 (1990).
27. Wilson, P.W. et al. Circulation 97, 1837-1847 (1998).
28. Lloyd-Jones, D.M., Larson, M.G., Beiser, A. & Levy, D. Lancet 353, 89-92 (1999).
29. Grundy, S.M. et al. Circulation 110, 227-239 (2004).
30. Kolodgie, F.D. et al. Heart 90, 1385-1391 (2004).
31. LaRosa, J.C. et al. N. Engl. J. Med. 352, 1425-1435 (2005).
32. Cannon, C.P., Steinberg, B.A., Murphy, S.A., Mega, J.L. & Braunwald, E. J. Am. Coll. Cardiol. 48, 438-445 (2006).
33. Cholesterol Treatment Trialists', (CTT) Collaboration et al. Lancet 376, 1670-1681 (2010).
34. Rashid, S. et al. Proc. Natl. Acad. Sci. USA 102, 5374-5379 (2005).
35. Qian, Y.W. et al. J. Lipid Res. 48, 1488-1498 (2007).
36. Goldstein, J.L. & Brown, M.S. Arterioscler. Thromb. Vasc. Biol. 29, 431-438 (2009).
37. Horton, J.D., Cohen, J.C. & Hobbs, H.H. J. Lipid Res. 50 (suppl.), S172-S177 (2009).
38. Steinberg, D. & Witztum, J.L. Proc. Natl. Acad. Sci. USA 106, 9546-9547 (2009).
39. Dhankhar, A., Evers, M. & Moller, M. in McKinsey Perspectives on Drug and Device R and D, 2-11 (2012).
40. Holm, H. et al. Nat. Genet. 43, 316-320 (2011).